Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
City of Hope Medical Center
City of Hope Medical Center
University of Chicago
St. Jude Children's Research Hospital
University of Washington
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
AIDS Malignancy Consortium
BioNTech SE
University of Colorado, Denver
NantCell, Inc.
Arog Pharmaceuticals, Inc.
Academic and Community Cancer Research United
Gilead Sciences
Arog Pharmaceuticals, Inc.
University of Nebraska
City of Hope Medical Center
National Cancer Institute (NCI)
University of Nebraska
University of Nebraska
Incyte Corporation
Eisai Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Florida
Northwestern University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Abramson Cancer Center at Penn Medicine
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Mereo BioPharma
G1 Therapeutics, Inc.
Fred Hutchinson Cancer Center
AbbVie
Abramson Cancer Center at Penn Medicine
Fred Hutchinson Cancer Center
Celgene
Fred Hutchinson Cancer Center
Eli Lilly and Company
University of Washington
Milton S. Hershey Medical Center
Georgetown University
National Cancer Institute (NCI)
ImmunoGen, Inc.
Memorial Sloan Kettering Cancer Center
Children's Oncology Group